Technical Analysis for HEMO - Hemogenyx Pharmaceuticals Plc

Grade Last Price % Change Price Change
F 4.15 -3.49% -0.15
HEMO closed down 3.49 percent on Friday, April 16, 2021, on 2.12 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical HEMO trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Older End-of-Day Signals for HEMO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% 1 day ago
3x Volume Pace 1 day ago
2x Volume Pace 1 day ago
1.5x Volume Pace 1 day ago
Up 3% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of novel therapies and treatments for blood diseases. It is developing products for bone marrow/hematopoietic stem cell BM/HSC transplant market, including CDX bi-specific antibody and CAR-T therapy for eliminating relapsed and/or refractory acute myeloid leukaemia, acute lymphoblastic leukaemia, and myelodysplastic syndrome; and Human Postnatal Hemogenic Endothelial Cells, a cell therapy product for BM/HSC transplants. Hemogenyx Pharmaceuticals Plc was founded in 2013 and is headquartered in London, the United Kingdom.

Keywords: Pharmaceutical Biotechnology Medicine Clinic Pharmaceuticals Disease Plants Branches Of Biology Diseases Medical Specialties Plastic Therapy Blood Rtt Dx Therapies Antibody Cell Therapy Refractory Stage Biotechnology Stem Cells Acute Myeloid Leukemia Cell Therapy Product Leukemia

Is HEMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 15.3875
52 Week Low 1.71
Average Volume 4,947,269
200-Day Moving Average 8.42
50-Day Moving Average 6.62
20-Day Moving Average 6.68
10-Day Moving Average 6.32
Average True Range 0.84
ADX 25.75
+DI 12.32
-DI 27.23
Chandelier Exit (Long, 3 ATRs ) 5.49
Chandelier Exit (Short, 3 ATRs ) 6.56
Upper Bollinger Band 8.77
Lower Bollinger Band 4.58
Percent B (%b) -0.1
BandWidth 62.66
MACD Line -0.45
MACD Signal Line -0.10
MACD Histogram -0.3429
Fundamentals Value
Market Cap 18 Million
Num Shares 434 Million
EPS -0.40
Price-to-Earnings (P/E) Ratio -10.38
Price-to-Sales 0.00
Price-to-Book 17.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.66
Resistance 3 (R3) 4.70 4.58 4.58
Resistance 2 (R2) 4.58 4.45 4.56 4.55
Resistance 1 (R1) 4.36 4.37 4.30 4.32 4.52
Pivot Point 4.24 4.24 4.21 4.22 4.24
Support 1 (S1) 4.02 4.11 3.96 3.98 3.78
Support 2 (S2) 3.90 4.03 3.88 3.75
Support 3 (S3) 3.68 3.90 3.73
Support 4 (S4) 3.64